Why did Circle stock surge after stablecoin bill?
How will Trump’s Iran delay affect markets?
What drives Kroger’s rising grocery demand?
Why is Tesla delaying robotaxi launch?
How are tariffs impacting used car sales?
What’s Meta’s strategy with AI-powered glasses?
Why did CNN executives quit ahead of spinoff?
FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder
benzinga.com/news/fda/25/06/46028780/fda-approves-regeneronm-sanofi-treatment-for-rare-autoimmune-skin-disorder
The U.S. Food and Drug Administration (FDA) on Friday approved Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Dupixent (dupilumab) for adult patients with bullous pemphigoid (BP), a rare, chronic autoimmune skin disorder.
BP primarily affects elderly patients…
This story appeared on benzinga.com, 2025-06-20 14:47:56.